Accelerated mammary tumor development in mutant polyomavirus middle T transgenic mice expressing elevated levels of either the Shc or Grb2 adapter protein

Molecular and Cellular Biology

Volumn 19, Issue 12, 1999, Pages 8169-8179

  Rauh, Michael J ^a   Blackmore, Valerie ^a   Andrechek, Eran R ^a   Tortorice, Christopher G ^a   Daly, Roger ^b   Lai, Venus Ka Man ^c   Pawson, Tony ^c   Cardiff, Robert D ^d   Siegel, Peter M ^a   Muller, William J ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b ST VINCENT S HOSPITAL   (Australia)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST TUMOR; ENZYME ACTIVATION; EPITHELIZATION; FEMALE; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS; POLYOMAVIRUS;

EID: 0033513541     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.19.12.8169     Document Type: Article

References (50)

1. Batzer, A. G., P. Blaikie, K. Nelson, J. Schlessinger, and B. Margolis. 1995. The phosphotyrosine interaction domain of Shc binds an LXNPXY motif on the epidermal growth factor receptor. Mol. Cell. Biol. 15:4403-4409.
2. Blaikie, P. A., E. Fournier, S. M. Dilworth, D. Birnbaum, J. P. Borg, and B. Margolis. 1997. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation. J. Biol. Chem. 272:20671-20677.
3. Bonfini, L., E. Migliaccio, G. Pelicci, L. Lanfrancone, and P. G. Pelicci. 1996. Not all Shc's roads lead to Ras. Trends Biochem. Sci. 21:257-261.
4. Bouchard, L., L. Lamarre, P. J. Tremblay, and P. Jolicoeur. 1989. Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene. Cell 57:931-936.
5. Campbell, K. S., E. Ogris, B. Burke, W. Su, K. K. Auger, B. J. Druker, B. S. Schaffhausen, T. M. Roberts, and D. C. Pallas. 1994. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc. Natl. Acad. Sci. USA 91:6344-6348.
6. Cheng, A. M., T. M. Saxton, R. Sakai, S. Kulkarní, G. Mbamaiu, W. Vogel, C. G. Tortorice, R. D. Cardiff, J. C. Cross, W. J. Muller, and T. Pawson. 1998. Mammalian Grb2 regulates multiple steps in embryonic development and malignant transformation. Cell 95:793-803.
7. Chirgwin, J. M., A. E. Przybyla, R. J. MacDonald, and W. J. Rutter. 1979. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294-5299.
8. Daly, R. J., M. D. Binder, and R. L. Sutherland. 1994. Overexpression of the Grb2 gene in human breast cancer cell lines. Oncogene 9:2723-2727.
9. Dankort, D. L., Z. Wang, V. Blackmore, M. F. Moran, and W. J. Muller. 1997. Distinct tyrosine autophosphorylation sites negatively and positively modulate new-mediated transformation. Mol. Cell. Biol. 17:5410-5425.
10. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
11. Gale, N. W., S. Kaplan, E. J. Lowenstein, J. Schlessinger, and D. Bar-Sagi. 1993. Grb2 mediates the EGF-dependent activation of guanine nucleotide exchange on Ras. Nature 363:88-92.
12. Gotoh, N., K. Muroya, S. Hattori, S. Nakamura, K. Chida, and M. Shibuya. 1995. The SH2 domain of Shc suppresses EGF-induced mitogenesis in a dominant negative manner. Oncogene 11:2525-2533.
13. Gotoh, N., M. Toyoda, and M. Shibuya. 1997. Tyrosine phosphorylation sites at amino acids 239 and 240 of Shc are involved in epidermal growth factor-induced mitogenic signaling that is distinct from Ras/mitogen-activated protein kinase activation. Mol. Cell. Biol. 17:1824-1831.
14. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1996. Activated neu induces rapid tumor progression. J. Biol. Chem. 271:7673-7678.
15. Guy, C. T., R. D. Cardiff, and W. J. Muller. 1992. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:954-961.
16. Guy, C. T., M. A. Webster, M. Schaller, T. J. Parsons, R. D. Cardiff, and W. J. Muller. 1992. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl. Acad. Sci. USA 89:10578-10582.
17. Harmer, S. L., and A. L. DeFranco. 1997. She contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes. Mol. Cell. Biol. 17:4087-4095.
18. Hashimoto, A., M. Kurosaki, N. Gotoh, M. Shibuya, and T. Kurosaki. 1999. Shc regulates epidermal growth factor-induced activation of the JNK signaling pathway. J. Biol. Chem. 274:20139-20143.
19. Hennighausen, L., and G. W. Robinson. 1998. Think globally, act locally: the making of a mouse mammary gland. Genes Dev. 12:449-455.
20. Huang, A. L., M. C. Ostrowski, D. Berard, and G. L. Hager. 1981. Glucocorticoid regulation of the Ha-MuSV p21 gene conferred by sequences from mouse mammary tumor virus. Cell 27:245-255.
21. Janes, P. W., R. J. Daly, A. deFazio, and R. L. Sutherland. 1994. Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9:3501-3608.
22. Krane, I. M., and P. Leder. 1996. NDF/heregulin induces persistence of terminal end buds and adenocarcinomas in the mammary glands of transgenic mice. Oncogene 12:1781-1788.
23. Lowenstein, E. J., R. J. Daly, A. G. Batzer, W. Li, B. Margolis, R. Lammers, A. Ullrich, E. Y. Skolnik, D. Bar-Sagi, and J. Schlessinger. 1992. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 70:431-442.
24. Melton, D. A., P. A. Krieg, M. R. Rebagliati, T. Maniatis, K. Zinn, and M. R. Green. 1984. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res. 12:7035-7056.
25. Muller, W. J., E. Sinn, P. K. Pattengale, R. Wallace, and P. Leder. 1988. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115.
26. Niemann, C., V. Brinkmann, E. Spitzer, G. Hartmann, M. Sachs, H. Naundorf, and W. Birchmeier. 1998. Reconstitution of mammary gland development in vitro: requirement of c-met and c-erbB2 signaling for branching and alveolar morphogenesis. J. Cell Biol. 143:533-545.
27. Pawson, T. 1994. SH2 and SH3 domains in signal transduction. Adv. Cancer Res. 64:87-110.
28. Pelicci, G., L. Dente, A De Giuseppe, B. Verducci-Galletti, S. Giuli, S. Mele, C. Vetriani, M. Giorgio, P. P. Pandolfi, G. Cesareni, and P. G. Pelicci. 1996. A family of Shc related proteins with conserved PTB, CH1 and SH2 regions. Oncogene 13:633-641.
29. Pelicci, G., L. Lanfrancone, F. Grignani, J. McGlade, F. Cavallo, G. Forni, I. Nicoletti, T. Pawson, and P. G. Pelicci. 1992. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell 70:93-104.
30. Pelicci, G., L. Lanfrancone, A. E. Salcini, A. Romano, S. Mele, M. Grazia Borrello, O. Segatto, P. P. Di Fiore, and P. G. Pelicci. 1995. Constitutive phosphorylation of Shc proteins in human tumors. Oncogene 11:899-907.
31. Rauh, M., and W. J. Muller. Unpublished observations.
32. Ricci, A., L. Lanfrancone, R. Chiari, G. Belardo, C. Pertica, P. G. Natali, P. G. Pelicci, and O. Segatto. 1995. Analysis of protein-protein interactions involved in the activation of the Shc/Grb-2 pathway by the ErbB-2 kinase. Oncogene 11:1519-1529.
33. Rozakis-Adcock, M., J. McGlade, G. Mbamalu, G. Pelicci, R. Daly, W. Li, A. Batzer, S. Thomas, J. Brugge, P. G. Pelicci, et al. 1992. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689-692.
34. Seed, B., and A. Aruffo. 1987. Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure. Proc. Natl. Acad. Sci. USA 84:3365-3369.
35. Semat, A., M. Vasseur, L. Maillet, P. Brulet, and Y. M. Darmon. 1988. Sequence analysis of murine cytokeratin endo A (no. 8) cDNA. Evidence for mRNA species initiated upstream of the normal 5′ end in PCC4 cells. Differentiation 37:40-46.
36. Siegel, P. M., E. D. Ryan, R. D. Cardiff, and W. J. Muller. 1999 Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: implications for human breast cancer. EMBO J. 18:2149-2164.
37. Sinn, E., W. Muller, P. Pattengale, I. Tepler, R. Wallace, and P. Leder. 1987. Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo. Cell 49:465-475.
38. Skolnik, E. Y., A. Batzer, N. Li, C. H. Lee, E. Lowenstein, M. Mohammadi, B. Margolis, and J. Schlessinger. 1993. The function of GRB2 in linking the insulin receptor to Ras signaling pathways. Science 260:1953-1955.
39. Skolnik, E. Y., C. H. Lee, A. Batzer, L. M. Vicentini, M. Zhou, R. Daly, M. J. Myers, Jr., J. M. Backer, A. Ullrich, M. F. White, et al. 1993. The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. EMBO J. 12: 1929-1936.
40. Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ulrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with the amplification of the HER2/neu oncogene. Science 235:177-182.
41. Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707-712.
42. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
43. Stevenson, L. E., and A. R. Frackelton, Jr. 1998. Constitutively tyrosine phosphorylated p52 Shc in breast cancer cells: correlation with ErbB2 and p66 Shc expression. Breast Cancer Res. Treat. 49:119-128.
44. Suen, K. L., X. R. Bustelo, T. Pawson, and M. Barbacid. 1993. Molecular cloning of the mouse grb2 gene: differential interaction of the Grb2 adaptor protein with epidermal growth factor and nerve growth factor receptors. Mol. Cell. Biol. 13:5500-5512.
45. van der Geer, P., and T. Pawson. 1995. The PTB domain: a new protein module implicated in signal transduction. Trends Biochem. Sci. 20:277-280.
46. van der Geer, P., S. Wiley, G. D. Gish, and T. Pawson. 1996. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/ 240) that mediate protein-protein interactions. Curr. Biol. 6:1435-1444.
47. Verbeek, B. S., S. S. Adriaansen-Slot, G. Rijksen, and T. M. Vroom. 1997. Grb2 overexpression in nuclei and cytoplasm of human breast cells: a histochemical and biochemical study of normal and neoplastic mammary tissue specimens. J. Pathol. 183:195-203.
48. Vonderhaar, B. K., and A. E. Greco. 1979. Lobulo-alveolar development of mouse mammary glands is regulated by thyroid hormones. Endocrinology 104:409-418.
49. Webster, M. A., J. N. Hutchinson, M. J. Rauh, S. K. Muthuswamy, M. Anton, C. G. Tortorice, R. D. Cardiff, F. L. Graham, J. A. Hassell, and W. J. Muller. 1998. Requirement for both Shc and phosphatidylinositol 3′ kinase signaling pathways in polyomavirus middle T-mediated mammary tumorigenesis. Mol. Cell. Biol. 18:2344-2359.
50. Yip, S. S., A. J. Crew, J. M. W. Gee, R. Hui, R. W. Blamey, J. F. R. Robertson, R. I. Nicholson, R. L. Sutherland, and R. J. Daly. 1999. Unpublished observations.